Artigos com autorizações de acesso público - Francesca DemichelisSaiba mais
GeralNIHEuropean CommissionCancer Research UKDoDDamon Runyon Cancer Research FoundationHHMIAIRC Foundation for Cancer Research in ItalyNIHRGovernment of ItalyProstate Cancer UKSNSFDFGMRCNSFCIHRHRBGovernment of SpainSCLV Foundation, USAGenome CanadaEMBLTelethonBBSRCWorldwide Cancer Research, UKDoris Duke Charitable FoundationAutism Speaks Inc, USALUNGevity Foundation, USARoyal Society UK
4 artigos não disponíveis publicamente
TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion
S Perner, JM Mosquera, F Demichelis, MD Hofer, PL Paris, J Simko, ...
The American journal of surgical pathology 31 (6), 882-888, 2007
Autorizações: German Research Foundation
Genetic predisposition to prostate cancer: Update and future perspectives
F Demichelis, JL Stanford
Urologic Oncology: Seminars and Original Investigations 33 (2), 75-84, 2015
Autorizações: US National Institutes of Health
MIMESIS: minimal DNA-methylation signatures to quantify and classify tumor signals in tissue and cell-free DNA samples
D Romagnoli, A Nardone, F Galardi, M Paoli, F De Luca, C Biagioni, ...
Briefings in Bioinformatics, 2023
Autorizações: Government of Italy
1314 RECURRENT MUTATIONS IN SPOP DEFINE A DISTINCT MOLECULAR CLASS OF PROSTATE CANCER
C Barbieri, S Baca, F Demichelis, M Lawrence, M Blattner, JP Theurillat, ...
The Journal of Urology 4 (187), e532-e533, 2012
Autorizações: US National Institutes of Health
128 artigos disponíveis publicamente
The landscape of somatic copy-number alteration across human cancers
R Beroukhim, CH Mermel, D Porter, G Wei, S Raychaudhuri, J Donovan, ...
Nature 463 (7283), 899-905, 2010
Autorizações: US National Institutes of Health, Howard Hughes Medical Institute
Integrative Clinical Genomics of Advanced Prostate Cancer
D Robinson, EM Van Allen, YM Wu, N Schultz, RJ Lonigro, JM Mosquera, ...
Cell 161 (5), 1215-1228, 2015
Autorizações: US National Institutes of Health, Howard Hughes Medical Institute, Cancer …
The molecular taxonomy of primary prostate cancer
A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ...
Cell 163 (4), 1011-1025, 2015
Autorizações: US National Institutes of Health
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
CE Barbieri, SC Baca, MS Lawrence, F Demichelis, M Blattner, ...
Nature Genetics 44 (6), 685-689, 2012
Autorizações: Swiss National Science Foundation, US National Institutes of Health, Howard …
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
H Beltran, D Prandi, JM Mosquera, M Benelli, L Puca, J Cyrta, C Marotz, ...
Nature medicine, 2016
Autorizações: US National Institutes of Health, European Commission, Damon Runyon Cancer …
Punctuated Evolution of Prostate Cancer Genomes
SC Baca, D Prandi, MS Lawrence, JM Mosquera, A Romanel, Y Drier, ...
Cell 153 (3), 666-677, 2013
Autorizações: Swiss National Science Foundation, US National Institutes of Health
The genomic complexity of primary human prostate cancer
MF Berger, MS Lawrence, F Demichelis, Y Drier, K Cibulskis, ...
Nature 470 (7333), 214-220, 2011
Autorizações: US National Institutes of Health, Howard Hughes Medical Institute
Genomic correlates of clinical outcome in advanced prostate cancer
W Abida, J Cyrta, G Heller, D Prandi, J Armenia, I Coleman, M Cieslik, ...
Proceedings of the National Academy of Sciences 116 (23), 11428-11436, 2019
Autorizações: US Department of Defense, US National Institutes of Health, Howard Hughes …
Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
H Beltran, DS Rickman, K Park, SS Chae, A Sboner, TY MacDonald, ...
Cancer Discovery 1 (6), 487-495, 2011
Autorizações: US National Institutes of Health
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer
P Mu, Z Zhang, M Benelli, WR Karthaus, E Hoover, CC Chen, ...
Science 355 (6320), 84-88, 2017
Autorizações: US Department of Defense, US National Institutes of Health, Howard Hughes …
Personalized in vitro and in vivo cancer models to guide precision medicine
C Pauli, BD Hopkins, D Prandi, R Shaw, T Fedrizzi, A Sboner, V Sailer, ...
Cancer Discovery 7 (5), 462-477, 2017
Autorizações: Swiss National Science Foundation, US Department of Defense, US National …
TMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
F Demichelis, K Fall, S Perner, O Andrén, F Schmidt, SR Setlur, ...
Oncogene 26 (31), 4596-4599, 2007
Autorizações: German Research Foundation
The long tail of oncogenic drivers in prostate cancer
J Armenia, SAM Wankowicz, D Liu, J Gao, R Kundra, E Reznik, ...
Nature genetics 50 (5), 645-651, 2018
Autorizações: US National Institutes of Health, V Foundation, USA
Clinical and genomic characterization of treatment-emergent small-cell neuroendocrine prostate cancer: a multi-institutional prospective study
R Aggarwal, J Huang, JJ Alumkal, L Zhang, FY Feng, GV Thomas, ...
Journal of Clinical Oncology 36 (24), 2492, 2018
Autorizações: US National Institutes of Health
TMPRSS2: ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer
S Perner, F Demichelis, R Beroukhim, FH Schmidt, JM Mosquera, S Setlur, ...
Cancer research 66 (17), 8337-8341, 2006
Autorizações: German Research Foundation
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma
N Palanisamy, B Ateeq, S Kalyana-Sundaram, D Pflueger, ...
Nature medicine 16 (7), 793-798, 2010
Autorizações: US National Institutes of Health, Howard Hughes Medical Institute, Canadian …
As informações de publicação e financiamento são determinadas automaticamente por um programa de computador